SBWire

Global Markets Direct's, 'Valens Therapeutics, Inc. - Product Pipeline Review - 2014', provides an overview of the Valens Therapeutics, Inc.'s pharmaceutical research and development focus.

CEL-SCI Corporation announced that during November it has added seven new clinical sites to its global pivotal Phase III head and neck cancer trial for its investigational immunotherapy Multikine* (Leukocyte Interleukin, Injection). Patient screening has begun at new clinical centers in France, Turkey, Poland, Sri Lanka, Russia and Taiwan.

Relmada Therapeutics, Inc., a clinical-stage company developing novel therapies for the treatment of chronic pain, announced today that it has appointed Christine Silverstein as director of investor relations, effective immediately. She will report to Michael Becker, senior vice president of finance and corporate development at Relmada.

Getting the right fertility medication from a trusted source is extremely important for anyone undertaking the treatment. The Pharmacists at Rox San are certified professionals with over 20 years experience working with doctors and advising patients. The range of medication in stock is extensive, and the pharmacy also provides a 24-hour phone support service for customers.

Innovus Pharmaceuticals, Inc., ("Innovus Pharma") (OTCQB:INNV) announced today it has expanded its exclusive marketing and distribution agreement with Tramorgan Limited ("Tramorgan") ,and granted to Tramorgan additional rights to market and sell Innovus Pharma's oral dietary supplement to promote sexual and cognitive health, Vesele® in the United Kingdom ("UK"). Under the agreement, Innovus is eligible to receive up to $13 million dollars in sales milestone payments plus fifty percent (50%) royalties based on Tramorgan's sales of Vesele® in the UK.

Hormone replacement therapy is used by both men and women in order to supplement the amount of hormone produced naturally by the body. As people age, the hormone balance changes and can have a range of effects that are sometimes undesirable. Hormone replacement therapy is the perfect way to mitigate these effects and maintain overall quality of life. Rox San Pharmacy as a professional compounding pharmacy is able to offer customized hormone therapy that provides the particular dosage form and strength on an individual basis.

Find out which medications work BEST BEFORE they're taken!

Global Markets Direct's, 'Acute Lung Injury - Pipeline Review, H2 2014', provides an overview of the Acute Lung Injury's therapeutic pipeline.

Global Markets Direct's, 'Adocia - Product Pipeline Review - 2014', provides an overview of the Adocia's pharmaceutical research and development focus.

Global Markets Direct's, 'Sickle Cell Disease - Pipeline Review, H2 2014', provides an overview of the Sickle Cell Disease's therapeutic pipeline.

Global Markets Direct's, 'AbGenomics International, Inc. - Product Pipeline Review - 2014', provides an overview of the AbGenomics International, Inc.'s pharmaceutical research and development focus.

Global Markets Direct's, 'Liver Cirrhosis - Pipeline Review, H2 2014', provides an overview of the Liver Cirrhosis's therapeutic pipeline.

Global Markets Direct's, 'Proliferative Vitreoretinopathy (PVR) - Pipeline Review, H2 2014', provides an overview of the Proliferative Vitreoretinopathy (PVR)'s therapeutic pipeline.

Global Markets Direct's, 'Ischemic Cerebral Stroke - Pipeline Review, H2 2014', provides an overview of the Ischemic Cerebral Stroke's therapeutic pipeline.

GlobalData's clinical trial report, "Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Global Clinical Trials Review, H2, 2014" provides data on the Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE). This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Global Markets Direct's, 'Agios Pharmaceuticals, Inc. - Product Pipeline Review - 2014', provides an overview of the Agios Pharmaceuticals, Inc.'s pharmaceutical research and development focus.

Global Markets Direct's, 'Argon Pharma S.L. - Product Pipeline Review - 2014', provides an overview of the Argon Pharma S.L.'s pharmaceutical research and development focus.

Global Markets Direct's, 'Skin And Soft Tissue Infections - Pipeline Review, H2 2014', provides an overview of the Skin And Soft Tissue Infections's therapeutic pipeline.

Global Markets Direct's, 'Nocturia - Pipeline Review, H2 2014', provides an overview of the Nocturia's therapeutic pipeline.

Global Markets Direct's, 'Kolon Life Science, Inc. - Product Pipeline Review - 2014', provides an overview of the Kolon Life Science, Inc.'s pharmaceutical research and development focus.

Global Markets Direct's, 'Generon (Shanghai) Corporation Ltd. - Product Pipeline Review - 2014', provides an overview of the Generon (Shanghai) Corporation Ltd.'s pharmaceutical research and development focus.

Global Markets Direct's, 'Vancomycin Resistant Staphylococcus Aureus Infection (VRSA) - Pipeline Review, H2 2014', provides an overview of the Vancomycin Resistant Staphylococcus Aureus Infection (VRSA)'s therapeutic pipeline.

Global Markets Direct's, 'Gamida Cell Ltd. - Product Pipeline Review - 2014', provides an overview of the Gamida Cell Ltd.'s pharmaceutical research and development focus.

Global Markets Direct's, 'Arterial Thrombosis - Pipeline Review, H2 2014', provides an overview of the Arterial Thrombosis's therapeutic pipeline.

Global Markets Direct's, 'Chlamydia Infections - Pipeline Review, H2 2014', provides an overview of the Chlamydia Infections's therapeutic pipeline.